Wed, November 2, 2022
Tue, November 1, 2022
Mon, October 31, 2022
Sun, October 30, 2022
Fri, October 28, 2022

Esther Hong Initiated (ACAD) at Hold and Held Target at $17 on, Nov 1st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-17-on-nov-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Esther Hong of Loop Capital, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Hold and Held Target at $17 on, Nov 1st, 2022.

Esther has made no other calls on ACAD in the last 4 months.



There are 8 other peers that have a rating on ACAD. Out of the 8 peers that are also analyzing ACAD, 4 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $15 on, Wednesday, August 10th, 2022
  • Vamil Divan of "Mizuho" Maintained at Hold with Decreased Target to $19 on, Wednesday, August 10th, 2022
  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $18 on, Tuesday, August 9th, 2022
  • Neena Bitritto-Garg of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $15 on, Monday, August 8th, 2022


These are the ratings of the 4 analyists that currently disagree with Esther


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $25 on, Tuesday, August 9th, 2022
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $21 on, Tuesday, August 9th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $21 on, Tuesday, August 9th, 2022
  • Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $21 on, Monday, August 8th, 2022

Publication Contributing Sources